In the news
Wanbury secures EDQM approval for Rivaroxaban API, USFDA clearances
Wanbury receives USFDA No DMF deficiency letter for Metformin HCl
Wanbury Shares Drop 7% After US FDA Concludes Inspection
Wanbury Expands API Market Access with Korea FDA Approval